Home Healthcare Biotechnology Gene Vector Market

Gene Vector Market Size, Share & Trends Analysis Report By Type (Viral Vectors, Non-Viral Vectors), By Application (Gene Therapy, Vaccinology, Others), By Diseases (Oncology, Genetic Disorders, Infectious Diseases, Others), By End Use (Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, CROs, CDMOs) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: November 26, 2025 | Author: Debashree B | Format: | Report Code: SR7433DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Gene Vector Market Size Analysis
    1. Introduction
    2. Gene Vector Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Viral Vectors
        1. Adenoviral vectors
        2. Adeno associated viral vectors
        3. Retroviral vectors
        4. Lentiviral vectors
        5. Herpes Simplex Virus (HSV) Vectors
        6. Others
      2. Non-Viral Vectors
        1. Plasmid DNA
        2. Lipid Nanoparticles
        3. Polymer-based Vectors
        4. Others
    3. Gene Vector Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Gene Therapy
      2. Vaccinology
      3. Others
    4. Gene Vector Market Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Genetic Disorders
      3. Infectious Diseases
      4. Others
    5. Gene Vector Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biotechnology Companies
      2. Academic & Research Institutes
      3. CROs
      4. CDMOs
  7. North America Gene Vector Market Size Analysis
    1. Introduction
    2. Gene Vector Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Viral Vectors
        1. Adenoviral vectors
        2. Adeno associated viral vectors
        3. Retroviral vectors
        4. Lentiviral vectors
        5. Herpes Simplex Virus (HSV) Vectors
        6. Others
      2. Non-Viral Vectors
        1. Plasmid DNA
        2. Lipid Nanoparticles
        3. Polymer-based Vectors
        4. Others
    3. Gene Vector Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Gene Therapy
      2. Vaccinology
      3. Others
    4. Gene Vector Market Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Genetic Disorders
      3. Infectious Diseases
      4. Others
    5. Gene Vector Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biotechnology Companies
      2. Academic & Research Institutes
      3. CROs
      4. CDMOs
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
  8. Europe Gene Vector Market Size Analysis
    1. Introduction
    2. Gene Vector Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Viral Vectors
        1. Adenoviral vectors
        2. Adeno associated viral vectors
        3. Retroviral vectors
        4. Lentiviral vectors
        5. Herpes Simplex Virus (HSV) Vectors
        6. Others
      2. Non-Viral Vectors
        1. Plasmid DNA
        2. Lipid Nanoparticles
        3. Polymer-based Vectors
        4. Others
    3. Gene Vector Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Gene Therapy
      2. Vaccinology
      3. Others
    4. Gene Vector Market Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Genetic Disorders
      3. Infectious Diseases
      4. Others
    5. Gene Vector Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biotechnology Companies
      2. Academic & Research Institutes
      3. CROs
      4. CDMOs
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    8. France
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
  9. APAC Gene Vector Market Size Analysis
    1. Introduction
    2. Gene Vector Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Viral Vectors
        1. Adenoviral vectors
        2. Adeno associated viral vectors
        3. Retroviral vectors
        4. Lentiviral vectors
        5. Herpes Simplex Virus (HSV) Vectors
        6. Others
      2. Non-Viral Vectors
        1. Plasmid DNA
        2. Lipid Nanoparticles
        3. Polymer-based Vectors
        4. Others
    3. Gene Vector Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Gene Therapy
      2. Vaccinology
      3. Others
    4. Gene Vector Market Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Genetic Disorders
      3. Infectious Diseases
      4. Others
    5. Gene Vector Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biotechnology Companies
      2. Academic & Research Institutes
      3. CROs
      4. CDMOs
    6. China
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    9. India
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
  10. Middle East and Africa Gene Vector Market Size Analysis
    1. Introduction
    2. Gene Vector Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Viral Vectors
        1. Adenoviral vectors
        2. Adeno associated viral vectors
        3. Retroviral vectors
        4. Lentiviral vectors
        5. Herpes Simplex Virus (HSV) Vectors
        6. Others
      2. Non-Viral Vectors
        1. Plasmid DNA
        2. Lipid Nanoparticles
        3. Polymer-based Vectors
        4. Others
    3. Gene Vector Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Gene Therapy
      2. Vaccinology
      3. Others
    4. Gene Vector Market Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Genetic Disorders
      3. Infectious Diseases
      4. Others
    5. Gene Vector Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biotechnology Companies
      2. Academic & Research Institutes
      3. CROs
      4. CDMOs
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
  11. LATAM Gene Vector Market Size Analysis
    1. Introduction
    2. Gene Vector Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Viral Vectors
        1. Adenoviral vectors
        2. Adeno associated viral vectors
        3. Retroviral vectors
        4. Lentiviral vectors
        5. Herpes Simplex Virus (HSV) Vectors
        6. Others
      2. Non-Viral Vectors
        1. Plasmid DNA
        2. Lipid Nanoparticles
        3. Polymer-based Vectors
        4. Others
    3. Gene Vector Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Gene Therapy
      2. Vaccinology
      3. Others
    4. Gene Vector Market Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Genetic Disorders
      3. Infectious Diseases
      4. Others
    5. Gene Vector Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biotechnology Companies
      2. Academic & Research Institutes
      3. CROs
      4. CDMOs
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Viral Vectors
          1. Adenoviral vectors
          2. Adeno associated viral vectors
          3. Retroviral vectors
          4. Lentiviral vectors
          5. Herpes Simplex Virus (HSV) Vectors
          6. Others
        2. Non-Viral Vectors
          1. Plasmid DNA
          2. Lipid Nanoparticles
          3. Polymer-based Vectors
          4. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Vaccinology
        3. Others
      4. Market Size & Forecast By Diseases 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Infectious Diseases
        4. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs
        4. CDMOs
  12. Competitive Landscape
    1. Gene Vector Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Lonza
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Thermo Fisher Scientific Inc.
    3. Catalent, Inc
    4. Charles River Laboratories
    5. WuXi AppTec
    6. Oxford Biomedica PLC
    7. Sartorius AG
    8. Takara Bio Inc.
    9. uniQure NV.
    10. Pfizer Inc.
    11. bluebird bio, Inc.
    12. Boehringer Ingelheim International GmbH
    13. Cytiva
    14. Revvity
    15. Forge Biologics
    16. GENE VECTOR BARCELONA S.L.
    17. Miltenyi Biotec
    18. Astellas Pharma Inc.
    19. Dyno
    20. Hoffmann-La Roche Ltd
    21. Others
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.